Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1993 2
1994 1
1995 1
1996 1
1997 1
1998 6
1999 1
2000 1
2001 2
2002 3
2003 6
2004 7
2005 7
2006 8
2007 3
2008 21
2009 22
2010 19
2011 30
2012 27
2013 35
2014 30
2015 18
2016 37
2017 36
2018 53
2019 49
2020 92
2021 71
2022 63
2023 8
Text availability
Article attribute
Article type
Publication date

Search Results

597 results
Results by year
Filters applied: . Clear all
Page 1
ABC Transporter-Mediated Multidrug-Resistant Cancer.
Amawi H, Sim HM, Tiwari AK, Ambudkar SV, Shukla S. Amawi H, et al. Among authors: sim hm. Adv Exp Med Biol. 2019;1141:549-580. doi: 10.1007/978-981-13-7647-4_12. Adv Exp Med Biol. 2019. PMID: 31571174 Review.
Hepatocellular carcinoma in the era of immunotherapy.
Sim HW, Knox J. Sim HW, et al. Curr Probl Cancer. 2018 Jan-Feb;42(1):40-48. doi: 10.1016/j.currproblcancer.2017.10.007. Epub 2017 Nov 15. Curr Probl Cancer. 2018. PMID: 29150141 Review.
Results of a United Kingdom real-world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory DLBCL.
Northend M, Wilson W, Osborne W, Fox CP, Davies AJ, El-Sharkawi D, Phillips EH, Sim HW, Sadullah S, Shah N, Peng YY, Qureshi I, Addada J, Mora RF, Phillips N, Kuhnl A, Davies E, Wrench D, McKay P, Karpha I, Cowley A, Karim R, Challenor S, Singh V, Burton C, Auer R, Williams C, Cunningham J, Broom A, Arasaretnam A, Roddie C, Menne T, Townsend W. Northend M, et al. Among authors: sim hw. Blood Adv. 2022 May 10;6(9):2920-2926. doi: 10.1182/bloodadvances.2021005953. Blood Adv. 2022. PMID: 35020818 Free PMC article. No abstract available.
Acetylation changes tau interactome to degrade tau in Alzheimer's disease animal and organoid models.
Choi H, Kim HJ, Yang J, Chae S, Lee W, Chung S, Kim J, Choi H, Song H, Lee CK, Jun JH, Lee YJ, Lee K, Kim S, Sim HR, Choi YI, Ryu KH, Park JC, Lee D, Han SH, Hwang D, Kyung J, Mook-Jung I. Choi H, et al. Among authors: sim hr. Aging Cell. 2020 Jan;19(1):e13081. doi: 10.1111/acel.13081. Epub 2019 Nov 25. Aging Cell. 2020. PMID: 31763743 Free PMC article.
Non-Abelian anyon collider.
Lee JM, Sim HS. Lee JM, et al. Among authors: sim hs. Nat Commun. 2022 Nov 4;13(1):6660. doi: 10.1038/s41467-022-34329-y. Nat Commun. 2022. PMID: 36333331 Free PMC article.
Management of glioblastoma: an Australian perspective.
Sim HW, Nowak AK, Lwin Z, Khasraw M. Sim HW, et al. Chin Clin Oncol. 2021 Aug;10(4):42. doi: 10.21037/cco.2020.02.05. Epub 2020 Feb 20. Chin Clin Oncol. 2021. PMID: 32075395 Free article. No abstract available.
Disease-specific eQTL screening reveals an anti-fibrotic effect of AGXT2 in non-alcoholic fatty liver disease.
Yoo T, Joo SK, Kim HJ, Kim HY, Sim H, Lee J, Kim HH, Jung S, Lee Y, Jamialahmadi O, Romeo S, Jeong WI, Hwang GS, Kang KW, Kim JW, Kim W, Choi M; Innovative Target Exploration of NAFLD (ITEN) consortium. Yoo T, et al. Among authors: sim h. J Hepatol. 2021 Sep;75(3):514-523. doi: 10.1016/j.jhep.2021.04.011. Epub 2021 Apr 20. J Hepatol. 2021. PMID: 33892010
Extracellular matrixes and neuroinflammation.
Jang DG, Sim HJ, Song EK, Kwon T, Park TJ. Jang DG, et al. Among authors: sim hj. BMB Rep. 2020 Nov;53(10):491-499. doi: 10.5483/BMBRep.2020.53.10.156. BMB Rep. 2020. PMID: 32731916 Free PMC article. Review.
597 results